David Kalergis, JD/MBA
Founder, Chairman and  & CEO (Full Time)

• Founder & Former CEO of Diffusion Pharmaceuticals Inc., a publicly-traded small molecule biotech firm in late-stage clinical trials
• Raised $150+ million from public and private equity markets and high net worth investors
• MBA/JD and BA from the University of Virginia

Peter Barton Hutt, LL.B
Director & Senior Thought Leader

• Senior Counsel, Covington & Burling LLP, specializing in Food and Drug Law
• Former General Counsel to the FDA
• Served on Board for 30+ biotech companies
• Harvard Law food & drug law teacher since 1994
• Member, National Academy of Medicine since 1971

Benjamin Gaston, MD

Member, Scientific Advisory Board

• Co-Inventor of the novel platform technology
• NIH and foundation funded for platform technology development
• Professor of Pediatrics and Vice Chair for Translational Research, Herman B Wells Center, Indiana University School of Medicine

James Bates, MD/PhD

Chief Medical Officer (Full Time)

• Co-Inventor of the novel platform technology
• Former practicing anesthesiologist, University of Iowa
• PhD, Biochemistry/Molecular Biology, University of California-Santa Barbara
• MD, Medicine, University of Miami School of Medicine

Stephen Lewis, PhD

Member, Scientific Advisory Board

• Co-Inventor of the novel platform technology
• NIH and foundation funded for platform technology development
• Professor, Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, Case Western Reserve University School of Medicine